Apollo Hospitals, Greams Road, Chennai has successfully performed more than 2,000 robotic-assisted orthopaedic surgeries, including total and partial knee replacements and total hip replacement procedures. The milestone marks a significant step in the hospital’s journey in technology-enabled joint replacement care and reflects its growing experience in combining advanced surgical systems with clinical expertise. The programme brings together Mako® SmartRobotics™ from Stryker, 3D CT-based imaging and detailed pre-operative planning to support patient-specific joint replacement procedures. The technology provides surgeons with detailed anatomical information, helping them develop and execute a surgical approach based on each patient’s anatomy and clinical requirements. While the robotic arm assists with execution of the pre-operative plan, treatment decisions and surgical judgement remain with the operating surgeon.For patients undergoing knee and hip replacement, the use of robotic assistance can support a minimally invasive surgical approach and may contribute to benefits including better overall alignment and accuracy, faster recovery and improved longevity of implants. For surgeons, the technology provides additional tools to assess anatomy, plan bone preparation and maintain consistency during the procedure, particularly when managing complex joint replacement cases.As part of the milestone, senior orthopaedic robotic surgeons - Dr Arun Kannan, Dr Kornad Kosygan, Dr Kunal Patel, Dr Navaladi Shankar, Dr Vijay Kishore Reddy and Dr Madhan Thiruvengada delivered keynote addresses highlighting the evolution of robotic-assisted joint replacement and the growing role of advanced technology in enabling more precise, personalised and patient-specific surgical care.In his keynote address, Dr Arun Kannan, Senior Orthopaedic Robotic Surgeon, Apollo Hospitals, Greams Road, said “Surpassing 2,000 robotic-assisted orthopaedic surgeries is a major milestone for our team and reflects the experience we have built over the years in robotic joint replacement. What makes this achievement particularly significant is the wide range of knee and hip replacement procedures we have performed, including complex cases. This experience has helped us understand where robotic assistance can add real value and how best to use it for each patient. Going forward, we will continue to build on this expertise, expand the use of robotic technology in orthopaedic care and focus on delivering safe, precise and personalised treatment for our patients.”Speaking at the occasion, Dr Ilankumaran Kaliamoorthy, CEO – Chennai Region, Apollo Hospitals, said, “This milestone reflects Apollo Hospitals’ continued focus on bringing meaningful advances in technology into clinical practice. The strength of our approach lies in bringing together experienced clinicians, advanced systems and a multidisciplinary care environment. As we expand our capabilities, our focus will remain on adopting technologies that can add value to patient care and support our clinicians in delivering better surgical outcomes.”The achievement forms part of Apollo Hospitals wider experience in robotic-assisted surgery across medical specialties. In February 2026, Apollo announced that it had crossed 8,000 robotic surgeries, highlighting its long-standing investment in advanced surgical capabilities. The 2,000-plus robotic-assisted orthopaedic procedures performed at Greams Road Hospital further add to this experience, strengthening the expertise in technology-enabled knee and hip replacement care.

Apollo Hospitals Navi Mumbai has launched a dedicated Geriatric Oncology Clinic for older adults with cancer, providing specialised assessment and personalised treatment planning based on an individual’s overall health and functional status rather than chronological age alone. The clinic is led by Dr. Tejinder Singh, Professor and Lead Consultant – Medical Oncology, Apollo Hospitals Navi Mumbai. Geriatric oncology addresses the specific considerations involved in treating cancer in older adults, who may differ considerably in their physical fitness, nutritional status, cognitive function, co-existing illnesses and ability to tolerate treatment. More than one-third of cancer patients treated at the hospital are above 60 years of age, highlighting the relevance of considering these factors alongside the type and stage of cancer when planning treatment.The clinic brings together medical oncologists, geriatricians, nutritionists, physiotherapists, psychologists and other specialists, providing coordinated care from diagnosis and treatment planning through supportive care and follow-up. A comprehensive geriatric assessment can help clinicians evaluate functional independence, nutrition, cognition, existing medical conditions and other vulnerabilities that may influence treatment decisions.Dr. Tejinder Singh said that cancer care for older adults cannot follow a one-size-fits-all model. He emphasised that age alone should not determine whether a patient is considered suitable for chemotherapy, immunotherapy, targeted therapy or surgery. Instead, treatment decisions should consider overall health, functional independence, nutritional and cognitive status, co-existing illnesses and the patient’s individual treatment goals.Building on this approach, Dr. Sayali Damle, Consultant – Geriatric Medicine, Apollo Hospitals Navi Mumbai, highlighted that geriatric oncology is not about offering less treatment to older patients, but about finding an appropriate balance between treatment benefit and potential risk. She noted that detailed geriatric assessment can help prevent undertreatment of fit patients who may benefit from cancer therapy and overtreatment of frail patients who may face avoidable complications, while also identifying risks early and addressing potentially reversible concerns.Through multidisciplinary assessment, personalised treatment planning and coordinated supportive care, the Geriatric Oncology Clinic aims to support older adults with cancer in receiving treatment tailored to their overall health, functional independence, ability to tolerate treatment and personal goals, alongside the characteristics of the cancer.

Success India Magazine has featured Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Limited, in an article examining her role in advancing Apollo Hospitals’ digital transformation. The feature explores Apollo’s adoption of artificial intelligence, robotic-assisted surgery, telehealth, remote care and digital therapeutics. It examines how these capabilities are being integrated across the organisation to support clinical care, extend access to health services and build a more connected healthcare ecosystem.The article also reflects on the Reddy family’s role in Apollo Hospitals’ growth and evolution, including the Group’s expansion beyond hospital-based care through digital platforms and technology-enabled services. Read the full article: https://successmagazine.in/preetha-reddy-leads-apollo-hospitals-digital/

Apollo Proton Cancer Centre (APCC), Chennai, hosted the 6th Annual Conference of the Particle Therapy Co-Operative Group – Asia-Oceania (PTCOG-AO 2026) from 4th to 6th September, marking the first time the regional conference was held in India. Conducted at Taj Fisherman’s Cove Resort & Spa, Chennai, the meeting brought together more than 450 delegates from 26 countries and regions. Centred on the theme “Empowering Access to Particle Therapy through Research, Education and Collaboration”, the three-day conference examined advances in the science, clinical application and technology of proton and other forms of particle therapy. It also explored the clinical evidence, infrastructure and workforce considerations involved in expanding access.The conference was led by Dr. Rakesh Jalali, Organising Chairman, PTCOG-AO 2026, and Medical Director and Senior Consultant – Radiation Oncology, APCC, and Dr. Srinivas Chilukuri, Scientific Chair (Clinical) and Organising Secretary, PTCOG-AO 2026, and Lead Consultant – Radiation Oncology, APCC. The scientific programme covered treatment planning and optimisation, radiobiology, medical physics, quality assurance, motion management and adaptive particle therapy. Sessions also examined emerging areas such as proton arc therapy, artificial intelligence and machine learning, biological modelling and FLASH radiotherapy, alongside disease-specific applications of particle therapy.Since introducing proton therapy in Chennai in 2019, APCC has developed its clinical programme alongside research, training and professional education. The conference provided a platform for institutions at different stages of developing particle-therapy services to exchange experience and explore collaborative research and capacity-building. A central focus was how to widen access through cost-conscious treatment protocols, high-volume treatment models, workforce development and appropriate patient selection. Discussions also addressed clinical research, health economics and the need to assess whether technological advances translate into meaningful benefits for patients.Dr. Preetha Reddy, Executive Vice-Chairperson, Apollo Hospitals Enterprise Limited, emphasised that efforts to expand advanced cancer care must remain evidence-based and focused on patient outcomes. She also highlighted India’s potential to contribute to cancer care globally, spanning prevention, early detection and precision treatment.Through PTCOG-AO 2026, specialists examined how clinical evidence, research, education and international collaboration can support more equitable access to particle therapy while ensuring its use remains appropriate and patient-centred.